Cargando…

Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression

BACKGROUND AND PURPOSE: Depression is one of the major psychiatric comorbidities associated with epilepsy. The inconclusive results of antidepressants (ADs) regarding their safety in regard to convulsions have strongly contributed towards under treatment of depression in people with epilepsy (PWE)....

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Rakesh Kumar, Singh, Tanveer, Mishra, Awanish, Goel, Rajesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Epilepsy Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540687/
https://www.ncbi.nlm.nih.gov/pubmed/28775952
http://dx.doi.org/10.14581/jer.17005
_version_ 1783254680827068416
author Sharma, Rakesh Kumar
Singh, Tanveer
Mishra, Awanish
Goel, Rajesh Kumar
author_facet Sharma, Rakesh Kumar
Singh, Tanveer
Mishra, Awanish
Goel, Rajesh Kumar
author_sort Sharma, Rakesh Kumar
collection PubMed
description BACKGROUND AND PURPOSE: Depression is one of the major psychiatric comorbidities associated with epilepsy. The inconclusive results of antidepressants (ADs) regarding their safety in regard to convulsions have strongly contributed towards under treatment of depression in people with epilepsy (PWE). Thus, the present study was envisaged to assess the relative safety of four different classes of ADs regarding their convulsive potential in kindled/epileptic animals. METHODS: Kindling (an animal model to induce chronic epilepsy) was induced in male Swiss albino mice by administration of pentylenetetrazole subconvulsive doses (35 mg/kg, i.p.) at an interval of 48 ± 2 h for 42 days. The epileptic animals were treated with saline; imipramine (20 mg/kg/day i.p.); fluoxetine (20 mg/kg/day i.p.); venlafaxine (10 mg/kg/day i.p.) and mirtazapine (10 mg/kg/day i.p.) for 15 days. Except naive, animals were challenged with pentylenetetrazole subconvulsive dose (35 mg/kg, i.p.) on every 5(th) day to determine convulsion severity score, latency to first myoclonic jerk, latency to first tonic-clonic convulsions and numbers of tonic-clonic convulsions. Depression was also evaluated every 5(th) day employing tail suspension test 2 h after pentylenetetrazole subconvulsive dose. RESULTS: All ADs have been reported significant antidepressant potential however regarding their safety in regard to convulsions in epileptic animals, variable results are obtained. Chronic administration of venlafaxine and mirtazapine were found to have significant anticonvulsant effect in epileptic animals. The behavioral data was further corroborated by neurochemical findings. CONCLUSIONS: The treatment with venlafaxine and mirtazapine can be considered safe for treatment of depression in epilepsy and may enhance anticonvulsant potential of antiepileptic drugs as an adjuvant therapy. However, pharmacokinetic studies are warranted before translating these findings in PWE.
format Online
Article
Text
id pubmed-5540687
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean Epilepsy Society
record_format MEDLINE/PubMed
spelling pubmed-55406872017-08-03 Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression Sharma, Rakesh Kumar Singh, Tanveer Mishra, Awanish Goel, Rajesh Kumar J Epilepsy Res Original Article BACKGROUND AND PURPOSE: Depression is one of the major psychiatric comorbidities associated with epilepsy. The inconclusive results of antidepressants (ADs) regarding their safety in regard to convulsions have strongly contributed towards under treatment of depression in people with epilepsy (PWE). Thus, the present study was envisaged to assess the relative safety of four different classes of ADs regarding their convulsive potential in kindled/epileptic animals. METHODS: Kindling (an animal model to induce chronic epilepsy) was induced in male Swiss albino mice by administration of pentylenetetrazole subconvulsive doses (35 mg/kg, i.p.) at an interval of 48 ± 2 h for 42 days. The epileptic animals were treated with saline; imipramine (20 mg/kg/day i.p.); fluoxetine (20 mg/kg/day i.p.); venlafaxine (10 mg/kg/day i.p.) and mirtazapine (10 mg/kg/day i.p.) for 15 days. Except naive, animals were challenged with pentylenetetrazole subconvulsive dose (35 mg/kg, i.p.) on every 5(th) day to determine convulsion severity score, latency to first myoclonic jerk, latency to first tonic-clonic convulsions and numbers of tonic-clonic convulsions. Depression was also evaluated every 5(th) day employing tail suspension test 2 h after pentylenetetrazole subconvulsive dose. RESULTS: All ADs have been reported significant antidepressant potential however regarding their safety in regard to convulsions in epileptic animals, variable results are obtained. Chronic administration of venlafaxine and mirtazapine were found to have significant anticonvulsant effect in epileptic animals. The behavioral data was further corroborated by neurochemical findings. CONCLUSIONS: The treatment with venlafaxine and mirtazapine can be considered safe for treatment of depression in epilepsy and may enhance anticonvulsant potential of antiepileptic drugs as an adjuvant therapy. However, pharmacokinetic studies are warranted before translating these findings in PWE. Korean Epilepsy Society 2017-06-30 /pmc/articles/PMC5540687/ /pubmed/28775952 http://dx.doi.org/10.14581/jer.17005 Text en Copyright © 2017 Korean Epilepsy Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sharma, Rakesh Kumar
Singh, Tanveer
Mishra, Awanish
Goel, Rajesh Kumar
Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression
title Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression
title_full Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression
title_fullStr Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression
title_full_unstemmed Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression
title_short Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression
title_sort relative safety of different antidepressants for treatment of depression in chronic epileptic animals associated with depression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540687/
https://www.ncbi.nlm.nih.gov/pubmed/28775952
http://dx.doi.org/10.14581/jer.17005
work_keys_str_mv AT sharmarakeshkumar relativesafetyofdifferentantidepressantsfortreatmentofdepressioninchronicepilepticanimalsassociatedwithdepression
AT singhtanveer relativesafetyofdifferentantidepressantsfortreatmentofdepressioninchronicepilepticanimalsassociatedwithdepression
AT mishraawanish relativesafetyofdifferentantidepressantsfortreatmentofdepressioninchronicepilepticanimalsassociatedwithdepression
AT goelrajeshkumar relativesafetyofdifferentantidepressantsfortreatmentofdepressioninchronicepilepticanimalsassociatedwithdepression